drugset / Trial / NCT05259098

Morphine vs Sufentanil PCA: Same Same or Different?

NCT05259098

Phase 4 Completed 54 enrolled Hospital Central do Funchal
RandomizedParallel-groupOpen-labelTreatment

Summary

Patient-controlled intravenous analgesia (PCA) has already proven its quality. However, with new strategies starting to emerge and the current concept of opioid sparing, it is a goal to find the optimal PCA strategy capable of improve patient satisfaction and, at the same time, individualize opioid dose. In a prospected randomized study, it was compared the use of Sufentanil Sublingual PCA System with intravenous PCA Morphine in terms of postoperative pain control satisfaction, total dose of opioid required, adverse effects, impact on the quality of postoperative recovery and the incidence of postoperative chronic pain.

Timeline

Start
2019-10-01
Primary completion
2020-06-30
Completion
2020-10-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Morphine Other / unclassified 1 mg Intravenous
Subject Sufentanil Other / unclassified 15 ug Other

Indications